SYDNEY, Dec. 28, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on Australian-listed growth companies, has the following companies covered:

• donation ltd SPX and Fiserv have entered into a two-year payment facilitator agreement under which Fiserv will provide direct trading facilities to Spenda’s customers. click here
• Island Pharmaceuticals Ltd ILAan Australian mid-stage antiviral drug development company has submitted an Investigational New Drug (IND) application for the Phase 2a PEACH clinical trial ISLA-101. click here
• Tempus Resources Ltd (TMRTMRR has increased its finances by CAD$680,100 (~AUD$747,939) following the completion of a non-brokered private placement. click here
• Paradigma Biopharmaceuticals Ltd PAR announced today that the first Data Monitoring Committee (DMC) safety review meeting for the pivotal PARA_OA_002 clinical study was conducted on December 20. click here

About Proactive

• Proactive is a unique technology-enabled platform that offers companies worldwide a comprehensive solution to engage investors throughout their business lifecycle.
  
• With six offices on three continents, Proactive works with innovative growth companies listed on the world’s major stock exchanges, helping executives connect intelligently with investors.
• In 2020, Proactive was featured in 809 million search results, our content was viewed over 165 million times and our readers spent over 10 million hours on our sites. Proactive has authored over 300,000 articles and 20,000 executive interviews since its inception in 2006.

For more information on how Proactive can help you make a difference, email us at action@proactiveinvestors.com.